Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy

WUN Partners with Biorasi for Rare Disease Day 2021

Conversations: a Peer-Peer Parent and Caregiver Discussion

Good @ Naps: Sleep Health Awareness Campaign by Wake Up Narcolepsy

Hypersomnia and Narcolepsy Study is Recruiting Participants

Conversations: a Peer-Peer Parent and Caregiver Discussion

New Narcolepsy App Seeking Beta Testers

Study Results- Perceived Challenges in Pediatric Narcolepsy: A Survey of Parents, Youth, and Sleep Physicians

Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA

Patient Recruitment Invitation for Narcolepsy Research Study